and not from a developmental defect in the neural circuitry. Furthermore, expressing orb2 just before training restored long-term memory whereas supplying it just after training did not. Therefore Orb2 is likely to function in mushroom body gamma neurons during or shortly after training, consistent with a role in the formation of long-term courtship memory.
Because Orb2 is thought to be a component of the synaptic tag and/or regulates the expression of tag components [1] , finding an acute role for orb2 in the gamma neurons of the mushroom bodies suggests that courtship (perhaps pheromone) memories are represented there. Using the same restoration of orb2 expression approach, it should be easy to localize courtship memories to a smaller subset of mushroom body gamma neurons. Furthermore, if it can be determined that Orb2 is indeed localized to the synapse, activated Orb2 may ultimately allow visualization of the memory-relevant individual synapses.
Keleman et al. [1] did not find a functional distinction between the Orb2A and B isoforms. It is possible that they are functionally redundant but differences may be revealed when they are expressed at lower level. It will be important to determine whether the A and B isoforms function in the same neurons and in the same way. It is worth noting that Orb2 belongs to the CPEB2 protein subfamily and that mammalian CPEB2-4 proteins bind sequences distinct from the cytoplasmic polyadenylation element [20] and therefore likely stimulate translation in a different way to CPEB1/Orb.
The obvious question that arises when finding a role for an RNA-binding protein (or transcription factor) in memory is the identity of the regulated transcripts. This is especially exciting for Orb2 because these mRNAs could reveal the necessary synaptic components of long-term memory and perhaps the physical nature of a synaptic tag. The results of Keleman et al. [1] are consistent with Orb2 itself being a component of the tag and provocatively, Orb2 variants that lack the prion-like amino terminus retain function sufficient for the flies to develop, but they cannot form, or sustain, long-term memory. It will therefore be important to determine whether the Orb2DQ protein localizes appropriately in neurons and whether the Orb2 amino terminus mediates binding to other proteins and/or whether prion-like Orb2 selfaggregation is the key to long-lasting memory [6, 7] . [1] is an almost universal recognition ligand. PS on apoptotic cells is recognized in a stereospecific manner (L-, but not D-phosphoserine) and stimulates the phagocyte both to engulf the apoptotic cell and to produce anti-inflammatory mediators, especially TGFb, which in turn inhibit production of pro-inflammatory chemokines and cytokines. Furthermore, oxidation of the fatty acyl groups appears to enhance PS recognition, at least by scavenger family receptors [2] . How PS arrives at the plasma membrane outer leaflet during apoptosis is still a mystery. Various phospholipid 'flip-floppases' (flip for inward, and flop for outward transbilayer movement) or 'floppases' have been identified, but none are universally expressed or definitively implicated in apoptosis [3] . During cell activation, enhanced transbilayer flip-flop of PS is thought to lead to PS exposure, which is then limited, temporally or spatially, by an active aminophospholipid translocase (APLT) that returns PS to the inner leaflet in living cells [4] . In aging erythrocytes, PS exposure accompanies the decline in APLT function [5] . PS exposure in apoptosis is associated with dramatic loss of APLT activity [6] , but also with the possible mixing of the plasma membrane with internal cell membranes [7] . Whether designated proteins or altered lipids or membrane composition [8] lead to PS exposure in apoptosis is an open question.
Recognition of the apoptosing cell by the phagocyte probably involves 'tethering' ligands and receptors as well as 'tickling' signals, including those derived from exposed PS [9] . This paradigm appears conserved throughout the metazoa. A PS receptor (PSR), along with a monoclonal antibody (mAb217) that was thought to recognize it, were originally described by Fadok et al. [10] . However, subsequent studies in a number of laboratories have demonstrated that this protein is primarily found in the nucleus and probably does not serve as a surface receptor at all. It contains a Jumonji domain (which may suggest a demethylase function) and is required for early development. Its possible participation in other elements of apoptotic cell clearance is currently unclear. However, engagement of phagocytes with mAb217 does appear to mimic recognition of PS-exposing apoptotic cells, though its ligand remains at large. Of note, while this PSR fell by the wayside, a number of PSrecognizing bridge molecules were described (e.g. Gas6 and protein S, MFG-E8 and Del-1; Figure 1) , which, acting through their respective receptors (Mer tyrosine kinase and a v integrins), provided a potential explanation for PS recognition [11, 12] . However, simultaneous efforts by three separate laboratories, using very different strategies have now identified three new PSRs, suggesting that the paradigm of PS-recognizing bridge molecules is not the final word.
Using an expression cloning approach Miyanishi et al. [13] have identified Tim4 (T-cell immunoglobulinand mucin-domain-containing molecule) as a PSR. Screening of hybridomas for antibodies that inhibit apoptotic cell phagocytosis led to the identification of the Kat5-18 antibody. A retrovirus-mediated expression cloning system and a cDNA library from mouse peritoneal macrophages was used to identify the antigen as Tim4, a protein detected in macrophages from many sites. Heterologous expression of Tim4 in fibroblasts induced 60% of the cells to phagocytose apoptotic cells. Furthermore, Kat5-18 blocked uptake of apoptotic cells in the thymus and led to the production of autoantibodies against double-stranded DNA and cardiolipin often associated with defective apoptotic cell uptake. Using lipid overlays, the immunoglobulin variable (IgV)-like domain of Tim4 (and the related family member Tim1) was shown to bind specifically to PS with a Kd of about 2 nM.
In a larger context, Tim4 and Tim1 belong to the TIM family proteins, known for homotypic and heterotypic binding to each other as well as to a diverse array of ligands [14] . Miyanishi et al. [13] went on to show that membrane expression of either Tim4 or Tim1 results in the binding of PS-exposing exosomes to the cells. These findings suggest that PS exposure detected during non-apoptotic cell stimulation might in some cases result from the binding by Tim4 or Tim1 to such exosomes, structures known to convey a variety of signals between cells. Both Tim1 and Tim4 are associated with T-cell activation and modulation of cytokine production from the T helper cell subsets Th1 and Th2. Furthermore, Tim1 has been identified as a susceptibility locus for the development of atopy and asthma [15] . As such, genetic polymorphisms of Tim1 and Tim4 and their interactions with PS-exposing apoptotic cells may shape the inflammatory milieu, contributing either to resolution of inflammation or perhaps toward atopy, asthma or autoimmunity.
Ravichandran's laboratory has previously shown that apoptotic cell engulfment involves ELMO and Dock180 acting together as a guanine nucleotide exchange factor for the small GTPase Rac. Using yeast two-hybrid screening to identify upstream ELMO-interacting proteins, they identified brain-specific angiogenesis inhibitor 1 (BAI1), a seven transmembrane protein belonging to the adhesion-type G-protein coupled receptor (GPCR) family [16] and expressed in brain, bone marrow, spleen and J774 macrophages. Expression of BAI1 in fibroblasts enhanced both binding and engulfment of apoptotic thymocytes and also induced PS liposomes. Significantly, siRNA-mediated knockdown of BAI1 blocked uptake of apoptotic cells in vitro, and injection of its extracellular domain prevented uptake in vivo. Mutational analysis showed that the a helix of the BAI1 intracellular domain was necessary and sufficient for ELMO binding. Furthermore, the trimeric complex of BAI1-ELMO-Dock180 was associated with enhanced Rac-GTP levels and the greatest increase in apoptotic cell uptake. Genetic manipulation of the BAI1 extracellular domain showed that its thrombospondin type 1 repeats (TSRs) were required for recognition of PS on apoptotic cells, and direct binding to lipid overlays showed stereospecific binding to PS.
Given the data supporting a role for thrombospondin 1 as a bridging molecule that recognizes apoptotic cells, the finding of TSRs at the business end of BAI1 is perhaps Nature repeating herself, and in this instance, providing the PS 'bridge' and downstream signaling unit in one package. One wonders whether BAI1 may also interact with other tethering receptors (such as CD36 and a v integrins) that are known to interact with thrombospondin 1 in the engulfment process. While there appears no obvious homolog of BAI1 in Caenorhabditis elegans (to signal through its homologs of ELMO and Dock180), other surface molecules containing TSRs might serve the same function in this and other species. The known role of BAI1 expression in the blockade of tumor neovascularization is intriguing, since, in many instances, apoptotic cell recognition is associated with angiogenesis. A conserved GPCR proteolytic cleavage site implicated in the release of the BAI1 extracellular domain (termed vasculostatin) and the subsequent demonstration that the resulting fragment blocks endothelial cell a v b 5 -dependent migration and proliferation [17] raise the question of whether, under some circumstances, proteolytic cleavage of BAI1 might paradoxically inhibit the recognition and uptake of apoptotic cells, an event associated with the development of autoimmunity.
The third PSR recently described is stabilin-2, a multifunctional receptor binding a large array of ligands, and perhaps best known for its scavenger receptor and endocytic functions. Park et al. [18] hypothesized that stabilin-2 might participate in the removal of aged, PS-exposing red blood cells (RBCs) and apoptotic cells. Overexpression of stabilin-2 in fibroblasts greatly enhanced both binding and engulfment of aged, but not normal, RBCs. Remarkably, tethered aged RBCs were engulfed within 2-4 seconds. Furthermore, both binding and engulfment were inhibited by an anti-stabilin-2 antibody and by knockdown of the protein using shRNA, and findings were similar when apoptotic cells were used as targets. Recognition was specific for PS in a stereospecific manner, though the responsible molecular sequences are unknown. Stabilin-2 expression was documented in human and mouse spleen, human monocyte-derived macrophages (HMDMs), alveolar macrophages, and several macrophage cell lines but not in J774.1 or Raw246.7 cells, which are often used in apoptotic The overall redundancy of PS recognition in response to apoptotic cells is also noteworthy and leads to critical questions about the signaling pathways employed. Of interest here, genetic analysis in C. elegans identified signaling molecules but provided very little evidence for recognition receptors, suggesting significant common usage of signal pathways with perhaps overlap and redundancy in the receptors. BAI1 was identified by its interaction with the ELMO-DOCK180 RacGEF signaling complex and both the Gas6-MerTK and MFG-E8-a v integrin complexes have also been shown to at least link to this complex [11] . Tim4 does not have a significant or obvious intracellular signaling domain and may therefore require a signaling partner -i.e. serve rather like a membrane-bound bridge molecule and/or predominantly as a tethering ligand. In other words, the finding of three new PS receptors raises many new issues, not the least of which is that it seems unlikely that we have yet found them all. How do they all interact? How is the redundancy played out in different tissues and on different cells and at different times? Finally, it is important to note that we can put to rest the concept that there is a single phosphatidylserine receptor -there are clearly many -and the originally identified PSR needs a new name. Sexual selection arises because individuals vary in reproductive success [1] . This variation often exceeds that in survivorship and sexual selection is thus a potentially powerful evolutionary force [2, 3] . Classically, sexual selection is viewed as comprising competition between
